Skip to main content

Articles

Page 48 of 65

  1. Survivin (BIRC5), a member of the inhibitor of apoptosis protein (IAP) family that inhibits caspases and blocks cell death is highly expressed in cancer and is associated with a poorer clinical outcome. Functioni...

    Authors: Ronan J Kelly, Ariel Lopez-Chavez, Deborah Citrin, John E Janik and John C Morris
    Citation: Molecular Cancer 2011 10:35
  2. Gene ablation studies have revealed that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, Apo2L, TNFSF10) plays a crucial role in tumor surveillance, as TRAIL-deficient mice exhibit an increased...

    Authors: Valerie Kedinger, Stephanie Muller and Hinrich Gronemeyer
    Citation: Molecular Cancer 2011 10:34
  3. The retinoblastoma product (RB1) is frequently deregulated in various types of tumors by mutation, deletion, or inactivation through association with viral oncoproteins. The functional loss of RB1 is recognize...

    Authors: Shinji Mizuarai, Takumitsu Machida, Tsutomu Kobayashi, Hideya Komatani, Hiraku Itadani and Hidehito Kotani
    Citation: Molecular Cancer 2011 10:31
  4. Oesophageal cancer is a highly aggressive tumour entity with at present poor prognosis. Therefore, novel treatment options are urgently needed. Hyaluronan (HA) is a polysaccharide present in the matrix of huma...

    Authors: Sören Twarock, Till Freudenberger, Eva Poscher, Guang Dai, Katharina Jannasch, Christian Dullin, Frauke Alves, Klaus Prenzel, Wolfram T Knoefel, Nikolas H Stoecklein, Rashmin C Savani, Bernhard Homey and Jens W Fischer
    Citation: Molecular Cancer 2011 10:30
  5. Gastric cancer is the fourth most common cancer in the world and the second most prevalent cause of cancer related death. The development of gastric cancer is mainly associated with H. Pylori infection leading to...

    Authors: Tony Bou Kheir, Ewa Futoma-Kazmierczak, Anders Jacobsen, Anders Krogh, Linda Bardram, Christoffer Hother, Kirsten Grønbæk, Birgitte Federspiel, Anders H Lund and Lennart Friis-Hansen
    Citation: Molecular Cancer 2011 10:29
  6. Aurora-A is a bona-fide oncogene whose expression is associated with genomic instability and malignant transformation. In several types of cancer, gene amplification and/or increased protein levels of Aurora-A...

    Authors: Florian Jantscher, Christine Pirker, Christoph-Erik Mayer, Walter Berger and Hedwig Sutterluety
    Citation: Molecular Cancer 2011 10:28
  7. Previous reports have suggested that the VEGF receptor neuropilin-1 (NRP-1) is expressed in a singly dispersed subpopulation of cells in the normal colonic epithelium, but that expression becomes dysregulated ...

    Authors: Danny CW Yu, Jonathan P Bury, James Tiernan, Jennifer S Waby, Carolyn A Staton and Bernard M Corfe
    Citation: Molecular Cancer 2011 10:27
  8. Epidermal growth factor receptor (EGFR) plays an essential role in normal development, tumorigenesis and malignant biology of human cancers, and is known to undergo intracellular trafficking to subcellular org...

    Authors: Xinyu Cao, Hu Zhu, Francis Ali-Osman and Hui-Wen Lo
    Citation: Molecular Cancer 2011 10:26
  9. Thromboxane synthase (TXS) metabolises prostaglandin H2 into thromboxanes, which are biologically active on cancer cells. TXS over-expression has been reported in a range of cancers, and associated with a poor...

    Authors: Mary-Clare Cathcart, Kathy Gately, Robert Cummins, Elaine Kay, Kenneth J O'Byrne and Graham P Pidgeon
    Citation: Molecular Cancer 2011 10:25
  10. While platinum-based chemotherapeutic agents are widely used to treat various solid tumors, the acquired platinum resistance is a major impediment in their successful treatment. Since enhanced DNA repair capac...

    Authors: Qi-En Wang, Keisha Milum, Chunhua Han, Yi-Wen Huang, Gulzar Wani, Jürgen Thomale and Altaf A Wani
    Citation: Molecular Cancer 2011 10:24
  11. Aneuploidy and chromosomal instability (CIN) are common abnormalities in human cancer. Alterations of the mitotic spindle checkpoint are likely to contribute to these phenotypes, but little is known about soma...

    Authors: Ivan Bièche, Sophie Vacher, François Lallemand, Sengül Tozlu-Kara, Hind Bennani, Michèle Beuzelin, Keltouma Driouch, Etienne Rouleau, Florence Lerebours, Hugues Ripoche, Géraldine Cizeron-Clairac, Frédérique Spyratos and Rosette Lidereau
    Citation: Molecular Cancer 2011 10:23
  12. Many hypotheses have been postulated to explain the intricate nature of the metastatic process, but none of them completely accounted for the actual biological and clinical observations. Consequently, metastas...

    Authors: Sandra Kraljevic Pavelic, Mirela Sedic, Hrvojka Bosnjak, Sime Spaventi and Kresimir Pavelic
    Citation: Molecular Cancer 2011 10:22
  13. FLASH is a huge nuclear protein involved in various cellular functions such as apoptosis signalling, NF-κB activation, S-phase regulation, processing of histone pre-mRNAs, and co-regulation of transcription. R...

    Authors: Anne Hege Alm-Kristiansen, Petra I Lorenzo, Ann-Kristin Molværsmyr, Vilborg Matre, Marit Ledsaak, Thomas Sæther and Odd S Gabrielsen
    Citation: Molecular Cancer 2011 10:21
  14. As well as inducing direct oncolysis, reovirus treatment of melanoma is associated with activation of innate and adaptive anti-tumour immune responses.

    Authors: Lynette Steele, Fiona Errington, Robin Prestwich, Elizabeth Ilett, Kevin Harrington, Hardev Pandha, Matt Coffey, Peter Selby, Richard Vile and Alan Melcher
    Citation: Molecular Cancer 2011 10:20
  15. Inhibitors of the kinase mTOR, such as rapamycin and everolimus, have been used as cancer therapeutics with limited success since some tumours are resistant. Efforts to establish predictive markers to allow se...

    Authors: Sampoorna Satheesha, Victoria J Cookson, Louise J Coleman, Nicola Ingram, Brijesh Madhok, Andrew M Hanby, Charlotte AB Suleman, Vicky S Sabine, E Jane Macaskill, John MS Bartlett, J Michael Dixon, Jim N McElwaine and Thomas A Hughes
    Citation: Molecular Cancer 2011 10:19
  16. Glioblastoma Multiforme (GBM) is the most common and invasive astrocytic tumor associated with dismal prognosis. Treatment for GBM patients has advanced, but the median survival remains a meager 15 months. In ...

    Authors: Avadhut D Joshi, D Williams Parsons, Victor E Velculescu and Gregory J Riggins
    Citation: Molecular Cancer 2011 10:17
  17. There are limited therapeutic options for hepatocellular carcinoma (HCC), the most common liver malignancy worldwide. Recent studies have identified the Frizzled-7 receptor (FZD7), important for activation of ...

    Authors: Wei Wei, Mei-Sze Chua, Susan Grepper and Samuel K So
    Citation: Molecular Cancer 2011 10:16
  18. The ductal carcinoma in situ (DCIS) of the mammary gland represents an early, pre-invasive stage in the development of invasive breast carcinoma. Since DCIS is a curable disease, it would be highly desirable to i...

    Authors: Céline Kretschmer, Anja Sterner-Kock, Friederike Siedentopf, Winfried Schoenegg, Peter M Schlag and Wolfgang Kemmner
    Citation: Molecular Cancer 2011 10:15
  19. Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an ant...

    Authors: Lalitha R Belur, Kelly M Podetz-Pedersen, Brent S Sorenson, Alice H Hsu, Josh B Parker, Cathy S Carlson, Daniel A Saltzman, S Ramakrishnan and R Scott McIvor
    Citation: Molecular Cancer 2011 10:14
  20. Interferon-gamma (IFNγ) is a multifunctional cytokine with antifibrotic and antiproliferative efficiency. We previously found that pancreatic stellate cells (PSC), the main effector cells in cancer-associated ...

    Authors: Falko Lange, Katja Rateitschak, Brit Fitzner, Ralf Pöhland, Olaf Wolkenhauer and Robert Jaster
    Citation: Molecular Cancer 2011 10:13
  21. Curcumin (diferuloylmethane) is a polyphenol derived from the Curcuma longa plant, commonly known as turmeric. Curcumin has been used extensively in Ayurvedic medicine for centuries, as it is nontoxic and has a v...

    Authors: Reason Wilken, Mysore S Veena, Marilene B Wang and Eri S Srivatsan
    Citation: Molecular Cancer 2011 10:12
  22. The importance of the malignant cell environment to its growth and survival is becoming increasingly apparent, with dynamic cross talk between the neoplastic cell, the leukocyte infiltrate and the stroma. Most...

    Authors: Adele Hannigan, Asif M Qureshi, Colin Nixon, Penelope M Tsimbouri, Sarah Jones, Adrian W Philbey and Joanna B Wilson
    Citation: Molecular Cancer 2011 10:11
  23. B-lymphoma Moloney murine leukemia virus insertion region-1 (Bmi-1) acts as an oncogene in various tumors, and its overexpression correlates with a poor outcome in several human cancers. Ectopic expression of ...

    Authors: Bao-Hong Guo, Yan Feng, Rong Zhang, Li-Hua Xu, Man-Zhi Li, Hsiang-Fu Kung, Li-Bing Song and Mu-Sheng Zeng
    Citation: Molecular Cancer 2011 10:10
  24. Despite recent advances in outlining the mechanisms involved in pancreatic carcinogenesis, precise molecular pathways and cellular lineage specification remains incompletely understood.

    Authors: Inamul Haque, Smita Mehta, Monami Majumder, Kakali Dhar, Archana De, Douglas McGregor, Peter J Van Veldhuizen, Sushanta K Banerjee and Snigdha Banerjee
    Citation: Molecular Cancer 2011 10:8
  25. Breast cancer is a disease characterised by both genetic and epigenetic alterations. Epigenetic silencing of tumour suppressor genes is an early event in breast carcinogenesis and reversion of gene silencing b...

    Authors: Cinzia Allegrucci, Michael D Rushton, James E Dixon, Virginie Sottile, Mansi Shah, Rajendra Kumari, Sue Watson, Ramiro Alberio and Andrew D Johnson
    Citation: Molecular Cancer 2011 10:7
  26. LIM kinase 1 (LIMK1) is an actin and microtubule cytoskeleton modulatory protein that is overexpressed in a number of cancerous tissues and cells and also promotes invasion and metastasis of prostate and breas...

    Authors: Tenekua Tapia, Richard Ottman and Ratna Chakrabarti
    Citation: Molecular Cancer 2011 10:6
  27. NEK1, the first mammalian ortholog of the fungal protein kinase never-in-mitosis A (NIMA), is involved early in the DNA damage sensing/repair pathway. A defect in DNA repair in NEK1-deficient cells is suggeste...

    Authors: Yumay Chen, Chi-Fen Chen, Huai-Chin Chiang, Michelle Pena, Rosaria Polci, Randy L Wei, Robert A Edwards, Donna E Hansel, Phang-Lang Chen and Daniel J Riley
    Citation: Molecular Cancer 2011 10:5
  28. Hepatocellular carcinoma has a high mortality rate due to its rate of recurrence. Acyclic retinoid prevents recurrence of hepatocellular carcinoma in patients after surgical removal of their primary tumors by ...

    Authors: Hideki Tatsukawa, Tetsuro Sano, Yayoi Fukaya, Naoto Ishibashi, Makiko Watanabe, Masataka Okuno, Hisataka Moriwaki and Soichi Kojima
    Citation: Molecular Cancer 2011 10:4
  29. SKI and SnoN proteins have been shown to inhibit TGF-β signaling, acting both as transcriptional co-repressors in the cell nucleus, and as sequestrators of SMAD proteins in the cytoplasm. TGF-β, on the other h...

    Authors: Delphine Javelaud, Leon van Kempen, Vasileia I Alexaki, Erwan Le Scolan, Kunxin Luo and Alain Mauviel
    Citation: Molecular Cancer 2011 10:2
  30. MicroRNAs (miRNAs) are involved in cancer development and progression, acting as tumor suppressors or oncogenes. Our previous studies have revealed that miR-148a and miR-152 are significantly down-regulated in...

    Authors: Yong-Xi Song, Zhen-Yu Yue, Zhen-Ning Wang, Ying-Ying Xu, Yang Luo, Hui-Mian Xu, Xue Zhang, Li Jiang, Cheng-Zhong Xing and Yong Zhang
    Citation: Molecular Cancer 2011 10:1
  31. Different isoforms of VEGF-A (mainly VEGF121, VEGF165 and VEGF189) have been shown to display particular angiogenic properties in the generation of a functional tumor vasculature. Recently, a novel class of VEGF-...

    Authors: Raúl Catena, Leyre Larzabal, Marta Larrayoz, Eva Molina, Jose Hermida, Jackeline Agorreta, Ramon Montes, Ruben Pio, Luis M Montuenga and Alfonso Calvo
    Citation: Molecular Cancer 2010 9:320
  32. FBI-1 (f actor that b inds to the i nducer of short transcripts of human immunodeficiency virus-1) is a member of the POK (POZ and Kruppel) family of transcription factors and play important roles in cellular dif...

    Authors: LiLi Jiang, Michelle KY Siu, Oscar GW Wong, Kar Fai Tam, Eric W-F Lam, Hextan YS Ngan, Xiao-Feng Le, Esther SY Wong, Hoi Yan Chan and Annie NY Cheung
    Citation: Molecular Cancer 2010 9:318
  33. Tumor resistance to the selective estrogen receptor modulator tamoxifen remains a serious clinical problem especially in patients with tumors that also overexpress HER2. We have recently demonstrated that the ...

    Authors: Diana M Cittelly, Partha M Das, Nicole S Spoelstra, Susan M Edgerton, Jennifer K Richer, Ann D Thor and Frank E Jones
    Citation: Molecular Cancer 2010 9:317
  34. Lymph node metastasis constitutes a key event in tumor progression. The molecular control of this process is poorly understood. Heparan sulfate is a linear polysaccharide consisting of unique sulfate-modified ...

    Authors: Xin Yin, Jadwiga Truty, Roger Lawrence, Scott C Johns, R Sathish Srinivasan, Tracy M Handel and Mark M Fuster
    Citation: Molecular Cancer 2010 9:316
  35. Perifosine, an alkylphospholipid tested in phase II clinical trials, modulates the extrinsic apoptotic pathway and cooperates with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to augment apo...

    Authors: Lei Fu, Yi-Dan Lin, Heath A Elrod, Ping Yue, Youtake Oh, Bo Li, Hui Tao, Georgia Z Chen, Dong M Shin, Fadlo R Khuri and Shi-Yong Sun
    Citation: Molecular Cancer 2010 9:315
  36. Malignant mesotheliomas (MM) have a poor prognosis, largely because of their chemoresistance to anti-cancer drugs such as doxorubicin (Dox). Here we show using human MM lines that Dox activates extracellular s...

    Authors: Arti Shukla, Jedd M Hillegass, Maximilian B MacPherson, Stacie L Beuschel, Pamela M Vacek, Harvey I Pass, Michele Carbone, Joseph R Testa and Brooke T Mossman
    Citation: Molecular Cancer 2010 9:314
  37. Many members of the ETS-domain transcription factor family are important drivers of tumourigenesis. In this context, their activation by Ras-ERK pathway signaling is particularly relevant to the tumourigenic p...

    Authors: Richard Keld, Baoqiang Guo, Paul Downey, Christian Gulmann, Yeng S Ang and Andrew D Sharrocks
    Citation: Molecular Cancer 2010 9:313
  38. MCT-1 oncoprotein accelerates p53 protein degradation via a proteosome pathway. Synergistic promotion of the xenograft tumorigenicity has been demonstrated in circumstance of p53 loss alongside MCT-1 overexpre...

    Authors: Ravi Kasiappan, Hung-Ju Shih, Meng-Hsun Wu, ChikOn Choy, Tai-Du Lin, Linyi Chen and Hsin-Ling Hsu
    Citation: Molecular Cancer 2010 9:311
  39. Beta-catenin is a multifunctional oncogenic protein that contributes fundamentally to cell development and biology. Elevation in expression and activity of β-catenin has been implicated in many cancers and ass...

    Authors: Maher S Saifo, Donald R Rempinski Jr, Youcef M Rustum and Rami G Azrak
    Citation: Molecular Cancer 2010 9:310
  40. Spontaneous interleukin-6 (IL-6) production has been observed in various tumors and implicated in the pathogenesis, progression and drug resistance in cancer. However, the regulation of IL-6 autocrine producti...

    Authors: Wei-Lun Huang, Hsuan-Heng Yeh, Chien-Chung Lin, Wu-Wei Lai, Jang-Yang Chang, Wen-Tsan Chang and Wu-Chou Su
    Citation: Molecular Cancer 2010 9:309
  41. Activation of the RON receptor tyrosine kinase, a member of the c-MET family, regulates tumorigenic phenotypes. The RON extracellular domains are critical in regulating these activities. The objective of this ...

    Authors: Qi Ma, Kun Zhang, Sunny Guin, Yong-Qing Zhou and Ming-Hai Wang
    Citation: Molecular Cancer 2010 9:307
  42. Human serum and other body fluids are rich resources for the identification of novel biomarkers, which can be measured in routine clinical diagnosis. microRNAs are small non-coding RNA molecules, which have an...

    Authors: Jan C Brase, Daniela Wuttig, Ruprecht Kuner and Holger Sültmann
    Citation: Molecular Cancer 2010 9:306

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    91 days submission to accept (Median)

    2023 Usage 
    3,569,666 downloads
    2,070 Altmetric mentions